An Institutional Febrile Neutropenia Protocol Improved the Antibacterial Treatment and Encouraged the Development of a Computerized Clinical Decision Support System

Zahit Taş, Gökhan Metan, Gülçin Telli Dizman, Eren Yavuz, Ömer Dizdar, Yahya Büyükaşık, Ömrüm Uzun, Murat Akova
{"title":"An Institutional Febrile Neutropenia Protocol Improved the Antibacterial Treatment and Encouraged the Development of a Computerized Clinical Decision Support System","authors":"Zahit Taş, Gökhan Metan, Gülçin Telli Dizman, Eren Yavuz, Ömer Dizdar, Yahya Büyükaşık, Ömrüm Uzun, Murat Akova","doi":"10.3390/antibiotics13090832","DOIUrl":null,"url":null,"abstract":"We investigated the influence of a local guideline on the quality of febrile neutropenia (FN) management and the applicability of a computerized decision support system (CDSS) using real-life data. The study included 227 FN patients between April 2016 and January 2019. The primary outcome measure was the achievement of a 20% increase in the rate of appropriate empirical treatment of FN in bacteremic patients. The compatibility of the CDSS (the development of which was completed in November 2021) with local protocols was tested using standard patient scenarios and empirical antibiotic recommendations for bacteremic FN patients. In total, 91 patients were evaluated before (P1: between April 2016 and May 2017) and 136 after (P2: between May 2017 and January 2019) the guideline’s release (May 2017). The demographic characteristics were similar. Appropriate empirical antibacterial treatment was achieved in 58.3% of P1 and 88.1% of P2 patients (p = 0.006). The need for escalation of antibacterial treatment was significantly lower in P2 (49.5% vs. 35.3%; p = 0.03). In P2, the performance of the CDSS and consulting physicians was similar (CDSS 88.8% vs. physician 88.83%; p = 1) regarding appropriate empirical antibacterial treatment. The introduction of the local guideline improved the appropriateness of initial empirical treatment and reduced escalation rates in FN patients. The high rate of compliance of the CDSS with the local guideline-based decisions in P2 highlights the usefulness of the CDSS for these patients.","PeriodicalId":8151,"journal":{"name":"Antibiotics","volume":"181 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Antibiotics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/antibiotics13090832","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

We investigated the influence of a local guideline on the quality of febrile neutropenia (FN) management and the applicability of a computerized decision support system (CDSS) using real-life data. The study included 227 FN patients between April 2016 and January 2019. The primary outcome measure was the achievement of a 20% increase in the rate of appropriate empirical treatment of FN in bacteremic patients. The compatibility of the CDSS (the development of which was completed in November 2021) with local protocols was tested using standard patient scenarios and empirical antibiotic recommendations for bacteremic FN patients. In total, 91 patients were evaluated before (P1: between April 2016 and May 2017) and 136 after (P2: between May 2017 and January 2019) the guideline’s release (May 2017). The demographic characteristics were similar. Appropriate empirical antibacterial treatment was achieved in 58.3% of P1 and 88.1% of P2 patients (p = 0.006). The need for escalation of antibacterial treatment was significantly lower in P2 (49.5% vs. 35.3%; p = 0.03). In P2, the performance of the CDSS and consulting physicians was similar (CDSS 88.8% vs. physician 88.83%; p = 1) regarding appropriate empirical antibacterial treatment. The introduction of the local guideline improved the appropriateness of initial empirical treatment and reduced escalation rates in FN patients. The high rate of compliance of the CDSS with the local guideline-based decisions in P2 highlights the usefulness of the CDSS for these patients.
机构发热性中性粒细胞减少症治疗方案改进了抗菌治疗并促进了计算机化临床决策支持系统的开发
我们利用真实数据调查了地方指南对发热性中性粒细胞减少症(FN)管理质量的影响以及计算机化决策支持系统(CDSS)的适用性。研究纳入了2016年4月至2019年1月期间的227名发热性中性粒细胞减少症患者。主要结果指标是菌血症患者 FN 的适当经验性治疗率提高 20%。CDSS (已于 2021 年 11 月完成开发)与当地协议的兼容性通过标准患者情景和针对菌血症 FN 患者的经验性抗生素建议进行了测试。在指南发布(2017 年 5 月)之前(P1:2016 年 4 月至 2017 年 5 月期间)和之后(P2:2017 年 5 月至 2019 年 1 月期间),共有 91 名患者接受了评估。人口统计学特征相似。58.3% 的 P1 患者和 88.1% 的 P2 患者接受了适当的经验性抗菌治疗(p = 0.006)。P2患者需要升级抗菌治疗的比例明显较低(49.5% 对 35.3%;p = 0.03)。在 P2,CDSS 和会诊医生在适当的经验性抗菌治疗方面的表现相似(CDSS 88.8% vs. 医生 88.83%;p = 1)。本地指南的引入提高了 FN 患者初始经验性治疗的适当性,降低了治疗升级率。CDSS 与 P2 病例中基于当地指南的决定的符合率很高,这凸显了 CDSS 对这些患者的实用性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信